Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Matrix-Targeting Immunotherapy Controls Tumor Growth and Spread by Switching Macrophage Phenotype.

Journal article

Deligne C. et al, (2020), Cancer immunol res, 8, 368 - 382

Structural Fuzziness of the RNA-Organizing Protein SERF Determines a Toxic Gain-of-interaction.

Journal article

Meyer NH. et al, (2020), J mol biol, 432, 930 - 951

Designing an improved T-cell mobilising CXCL10 mutant through enhanced GAG binding affinity.

Journal article

Gerlza T. et al, (2019), Protein eng des sel, 32, 367 - 373

More Than Just Attractive: How CCL2 Influences Myeloid Cell Behavior Beyond Chemotaxis.

Journal article

Gschwandtner M. et al, (2019), Front immunol, 10

Glycosaminoglycans are important mediators of neutrophilic inflammation in vivo.

Journal article

Gschwandtner M. et al, (2017), Cytokine, 91, 65 - 73

Interfering with the CCL2-glycosaminoglycan axis as a potential approach to modulate neuroinflammation.

Journal article

Gschwandtner M. et al, (2016), Neurosci lett, 626, 164 - 173

Preparation and Characterization of Glycosaminoglycan Chemokine Coreceptors.

Journal article

Kitic N. et al, (2016), Methods enzymol, 570, 517 - 538

Glycosaminoglycan silencing by engineered CXCL12 variants.

Journal article

Gschwandtner M. et al, (2015), Febs lett, 589, 2819 - 2824